Citi Slashes Bitcoin Target as Crypto Rally Slows in U.S.
Citigroup slashed its one-year targets for Bitcoin and Ethereum, citing a delayed U.S. policy timetable that dampens ...
Ways To Cut Costs On A Limited Budget
Learn various ways to cut costs on a limited budget. Make smarter financial choices and save effectively.
21,848 articlesSpaceX Stock Down From Peak: What History Suggests Next
SpaceX has captured headlines with a blockbuster IPO, but the stock has cooled. This article breaks down how historic...
Unicorns Flush with Cash Face Cap Table Gridlock in 2026
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
Philadelphia Anchor Shared Code Sparks Scam Wave: What to Do
A CBS Philadelphia anchor became a reminder that scammers exploit trusted voices. Learn how the philadelphia anchor s...
Rate Chance Hits Zero: Bitcoin Emerges as Inflation Hedge
With rate-cut bets disappearing, traders pivot to potential rate hikes and Bitcoin’s role as a long-term hedge agains...
Metamask Code Open North Linked Contractor Scrutiny
Consensys says a third-party contractor linked to North Korea accessed MetaMask code for roughly a month before acces...
This $6.5 Million Healthcare Move Drives Investor Signals
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
Nvidia Trades Times Forward: Is It a Real Value Play Today?
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...
Prediction Market Pegs SpaceX's IPO Day: 62% Forecast for $2 Trillion Valuation
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...
Oklo Down From Peak: What Investors Should Know Now
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status